Finnish researcher Jyrki Ali-Yrkkö, of the Helsinki School of Economics, has shown it is possible to increase the R&D activities of companies through public funding.
Record venture capital and heated deal environment propelled biotechnology industry forward in 2007, says Ernst & Young’s biotech report for last year.
The controversy over embryonic stem cell research will not dissipate until the technology proves itself in the clinic. Now the regulators have to move, say Science|Business’s Nuala Moran.
The UK Technology Strategy Board has published its three-year strategic plan and outlined how it will promote and invest in technology-driven innovation.
Five of the UK’s major funders of animal research will make compliance with their guidelines a condition of funding for new grants involving the use of animals.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.